secwatch / observer
8-K filed February 25, 2025, 6:59 PM ET ticker ZBH CIK 0001136869
leadership confidence high sentiment neutral materiality 0.55

Zimmer Biomet announces Chairman Christopher Begley to retire; CEO Ivan Tornos to succeed as Chair

ZIMMER BIOMET HOLDINGS, INC.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ivan Tornos

Chairman of the Board
ZBH · ZIMMER BIOMET HOLDINGS, INC.
Effective
2025-05-29
Filed
February 25, 2025, 6:59 PM ET
has appointed Ivan Tornos, the Company’s President, Chief Executive Officer and a director, as the Chairman of the Board, effective on May 29, 2025
Departed

Christopher Begley

Chairman of the Board
ZBH · ZIMMER BIOMET HOLDINGS, INC.
Effective
2025-05-29
Successor
Ivan Tornos
Filed
February 25, 2025, 6:59 PM ET
Christopher Begley, the Company’s Chairman of the Board, is not eligible for nomination by the Board for election as a director at the 2025 Annual Meeting and will retire from the Board when his current term expires at such meeting.
Appointed

Michael Farrell

Lead Independent Director
ZBH · ZIMMER BIOMET HOLDINGS, INC.
Effective
2025-05-29
Filed
February 25, 2025, 6:59 PM ET
has appointed Michael Farrell to be the Lead Independent Director of the Board, effective upon the commencement of Mr. Tornos’ service as Chairman.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ivan Tornos was appointed as Chairman of the Board at ZIMMER BIOMET HOLDINGS, INC..

Action
appointed
Role
Chairman of the Board
Exact text from the filing
has appointed Ivan Tornos, the Company’s President, Chief Executive Officer and a director, as the Chairman of the Board, effective on May 29, 2025
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Begley departed as Chairman of the Board at ZIMMER BIOMET HOLDINGS, INC..

Action
will retire
Role
Chairman of the Board
Exact text from the filing
Christopher Begley, the Company’s Chairman of the Board, is not eligible for nomination by the Board for election as a director at the 2025 Annual Meeting and will retire from the Board when his current term expires at such meeting.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Michael Farrell was appointed as Lead Independent Director at ZIMMER BIOMET HOLDINGS, INC..

Action
appointed
Role
Lead Independent Director
Exact text from the filing
has appointed Michael Farrell to be the Lead Independent Director of the Board, effective upon the commencement of Mr. Tornos’ service as Chairman.
View on SEC.gov

ZIMMER BIOMET HOLDINGS, INC. filing history →

Source: SEC EDGAR
accession 0001193125-25-035147
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.